摘要
目的:探讨增殖型糖尿病视网膜病变(PDR)血管生成因子的表达谱。 方法:从10例糖尿病PDR患者玻璃体标本进行稀释(10眼)和9个非糖尿病患者(9眼)。通过raybio血管生成细胞因子抗体芯片检测玻璃体样本60的促血管生成因子的浓度。酶联免疫吸附试验(ELISA)进一步证实了玻璃体液中的差异表达因子。 结果:与非糖尿病对照组相比,PDR患者的20个差异表达因子有1.50倍以上的变化。血管内皮生长因子(VEGF)的平均浓度,白细胞介素6(IL-6)、血管生成素(Ang)1、Ang-2、尿激酶型纤溶酶原激活物受体(uPAR)、Follistatin和基质金属蛋白酶9(MMP-9)显著增加玻璃体标本PDR相比对照组(P<0.05)。然而,(MCP)1,Angiogenin和瘦素水平明显低于PDR相比对照组(P<
关键词: 糖尿病,视网膜病变,血管生成,玻璃体,增殖性糖尿病视网膜病变,ELISA。
Current Molecular Medicine
Title:The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy
Volume: 17 Issue: 4
关键词: 糖尿病,视网膜病变,血管生成,玻璃体,增殖性糖尿病视网膜病变,ELISA。
摘要: Objective: To explore the expression profile of angiogenic factors associated with proliferative diabetic retinopathy (PDR).
Methods: Undiluted vitreous humor samples were obtained from 10 diabetic patients with PDR (10 eyes) and 9 non-diabtic patients (9 eyes). The concentrations of 60 angiogenic factors in the vitreous humor samples were measured by RayBio Angiogenic Cytokine Antibody Array. Some differentially expressed factors were further confirmed in vitreous humor by enzyme-linked immunosorbent assay (ELISA).
Results: Compared with the non-diabetic controls, 20 differentially expressed factors with more than 1.50 fold changes were detected in patients with PDR. The median concentration of vascular endothelial growth factor (VEGF), interleukin 6 (IL-6), angiopoietin (ANG)-1, ANG-2, urokinase-type plasminogen activator receptor (uPAR), Follistatin and matrix metalloproteinases 9 (MMP-9) was significantly increased in vitreous samples from PDR compared to controls (P < 0.05). However, (MCP)-1, Angiogenin and Leptin was significantly lower in PDR eyes compared to controls (P < 0.05). In the verification assay using ELISA, ANG-1, ANG-2, IL-6, VEGF, MMP-9, hepatocyte growth factor (HGF) and placenta growth factor (PIGF) concentration were increased in patients with PDR compared to controls (all P-values < 0.05).
Conclusion: This is the first report of a comprehensive multiplex analysis to identify angiogenic factors associated with PDR. These angiogenic factors may contribute to the pathogenesis of PDR and may be targets for therapeutic strategies of PDR.
Export Options
About this article
Cite this article as:
The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy, Current Molecular Medicine 2017; 17 (4) . https://dx.doi.org/10.2174/1566524017666171106111440
DOI https://dx.doi.org/10.2174/1566524017666171106111440 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases
Current Pharmaceutical Design Targeting Potassium Channels: New Advances in Cardiovascular Therapy
Recent Patents on Cardiovascular Drug Discovery Arterial Spin Labeling Perfusion MRI in Alzheimers Disease
Current Medical Imaging Potential Options to Treat Hypertriglyceridaemia
Current Drug Targets Preface [Hot Topic: Antihypertensive Drugs (Executive Editor : Gregory Y.H. Lip)].
Current Pharmaceutical Design The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity
Current Neurovascular Research Role of Salt and Potassium in Hypertension and the Associated Organ Damages
Current Hypertension Reviews Hsp90 Flexibility and Development of its Inhibitors for the Treatment of Cancer
Current Chemical Biology A Random Forest Model to Predict the Activity of a Large Set of Soluble Epoxide Hydrolase Inhibitors Solely Based on a Set of Simple Fragmental Descriptors
Combinatorial Chemistry & High Throughput Screening Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors
Current Neurovascular Research UHPLC-ESI-QToF Analysis of Trandolapril and Verapamil Hydrochloride in Dosage Form and Spiked Human Plasma Using Solid Phase Extraction: Stability Indicating Assay Method
Current Pharmaceutical Analysis Managing Bleeding Complications in Patients Treated with the Old and the New Anticoagulants
Current Pharmaceutical Design Acute Kidney Injury in Pediatric Heart Failure
Current Cardiology Reviews Design and Optimization of a Novel Spectrophotometric Method using Response Surface Methodology for the Determination of Los artan Potassium in Pharmaceuticals
Current Pharmaceutical Analysis Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies
Current Medicinal Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery May Oxygen-Ozone Therapy Improves Cardiovascular Disorders?
Cardiovascular & Hematological Disorders-Drug Targets Pharmacological Properties of Indazole Derivatives: Recent Developments
Mini-Reviews in Medicinal Chemistry Ganoderma lucidum: A Potent Pharmacological Macrofungus
Current Pharmaceutical Biotechnology Perinatal Management of Fetal Tumors
Current Pediatric Reviews